Background
==========

In the Preventive Angioplasty in Myocardial Infarction trial (PRAMI; ISRCTN73028481), immediate multivessel PCI (MV-PCI) of non-IRA (infarct related artery) lesions in patients with acute ST elevation myocardial infarction (STEMI) and multivessel coronary disease (MVD) improved long term prognosis. We assessed infarct distribution and size in a pre-specified cardiac magnetic resonance (CMR) sub-study.

Methods
=======

In this single centre prospective sub-study, PRAMI participants were invited to undergo 1.5 Tesla CMR 1 week and 1 year after primary PCI. The CMR scans were analysed using semi-automated software by a clinician blinded to treatment group assignment and clinical outcomes. The presence and extent of infarction were assessed quantitatively with late gadolinium enhancement (LGE) imaging (Gadovist, 0.1 mmol/kg). The infarct was delineated as an area of myocardial enhancement (cm^2^) using a signal intensity threshold of \>5SDs above a remote region, and expressed as a % of total LV mass. The incidence of new LGE in non-infarct related artery territories at baseline and 1 year were assessed. Data were analysed by an independent statistician.

Results
=======

Of 465 randomised trial participants in 6 UK hospitals, 138 (30%) were enrolled in Glasgow. Of these 80 patients underwent CMR 1 week post primary PCI of whom 41 (51%) were in the multi-vessel PCI group and 39 (49%) were in the IRA-only group. At 1 year, 69 (86%) patients had a follow up CMR scan. Infarct size and distribution are described in Table [1](#T1){ref-type="table"}.

###### 

Infarct size and distribution in non-infarct artery territory in the randomised PRAMI trial participants (n=80) in Glasgow.

                                                      Infarct-only PCI n = 39 (49%)   Multivessel PCI n=41 (51%)   p
  --------------------------------------------------- ------------------------------- ---------------------------- ------
  1 week post-MI                                                                                                   
                                                                                                                   
  Infarct size, % LV′                                 16.9 (14.0)                     13.9 (12.1)                  0.32
                                                                                                                   
  Infarct in non-IRA territory, n (%)                 0 (0)                           0 (0)                        1.00
                                                                                                                   
  1 year post-MI                                                                                                   
                                                                                                                   
  Infarct size, % LV                                  13.9 (10.1)                     11.1 (11.2)                  0.20
                                                                                                                   
  Change in infarct size from baseline, % LV mass\*   -2.23 ( -9.97, 0.56)            -1.73 (-7.10, 0.94)          0.60
                                                                                                                   
  Infarct in non-IRA territory, n (%)                 2 (5.1)                         3 (7.3)                      1.00

′ mean (standard deviation)

\*median (interquartile range)

Conclusions
===========

Infarct size and distribution were similar in patients treated by MV-PCI or IRA-only PCI. MV-PCI is not associated with additional MI acutely which supports the safety of this procedure in line with the benefits observed with preventive PCI in PRAMI.
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